European Foundation for the Study of Diabetes (EFSD)
and
Novo Nordisk
Partnership for Diabetes Research in
Europe
Request for Applications
EFSD and Novo Nordisk
announce funding
of Research Grants in 2010
Deadline date: 01 April 2010
Background
The European Foundation for the Study of Diabetes (EFSD) was
created by the European Association for the Study of Diabetes (EASD) to provide
multiple funding initiatives in all areas of diabetes research. The aims of EFSD
are to encourage and support research in the field of diabetes, to rapidly
diffuse acquired knowledge and to facilitate its application.
Novo Nordisk is a healthcare company and a world leader in diabetes
care. Novo Nordisk manufactures and markets pharmaceutical products and services
that make a significant difference to patients, the medical profession and
society. With headquarters in Denmark, Novo Nordisk employs approximately 29,000
employees in 81 countries, and markets its products in 179 countries.
Programme Research and Focus
The EFSD/Novo Nordisk
Partnership for Diabetes Research in Europe Programme will accept applications
from all fields of diabetes research and including both basic and clinical
research.
Funding
Up to Euro 3 million has been made available for research grants for projects to
be performed in Europe and its associated countries.
Research will be supported through the award of grants
of up to Euro 100,000 for basic research projects and Euro 400,000 for clinical
research projects. The duration of each award will depend upon the needs of the
project and as justified in the application.
Applications with a funding
requirement larger than the amounts specified above may be considered; in this
case, the total funding requirement should be indicated and justified in the
budget section of the application.
According to the duration and timetable of the project, funds will be made
annually.
Mechanism of Support and Review
Applications for a grant through this Programme are invited from single
non-profit institutions or groups of such institutions from
Europe
and associated countries. The principal
investigator and any co-investigators must be normally employed at a non-profit
institution and the study must be performed at their place of work.
Applications will be subject to a scientific review by a specialised
and independent ad hoc
committee. Funding will require approval by a Programme Board convened for this
purpose, and will be awarded by July 2010.
Prior to any final decision on funding, and in order to offer applicants the
opportunity to benefit from the review process, EFSD reserve the right to
request revision to applications in accordance with the recommendations of the
Review Committee.
Research Grant Applications
Applications for research grants may be subjected to
pre-review (or triage) procedures. In this event, any application rejected at
pre-review will not be subject to a complete scientific review. The deadline for
receipt of research grant applications for funding this year
01 April 2010.
All budgets are to be prepared in Euro. For countries in which
the Euro is not yet the common currency, the exchange rate (between the Euro and
the local currency in the country where the work is to be performed) used for
calculating the Euro budget must be mentioned under "Budget Justification".
Application forms
may be
downloaded here
All applications must be prepared on the official forms and
completed in strict accordance with the detailed instructions to be found on
these forms. In particular, applicants are reminded that any pages in addition
to the maximum of 10 allowed for the scientific section of the application will
be deleted prior to review. Similarly, no applications using a font or
line-spacing smaller than that defined in the instructions will be considered
for review. Additional material (in the form of an appendix, attachment,
reprints, etc.) will not be accepted.
Postal applications should be received in the EFSD Office no
later than 01 April 2010. Please send to:
European Foundation for the Study of Diabetes
Rheindorfer Weg 3
40591 Düsseldorf, Germany
Tel: +49-211-75 84 69 0
Fax: + 49-211-75 84 69 29
Review Considerations
Completed applications will be evaluated in accordance with the criteria stated below for scientific/technical
merit by an appropriate scientific committee convened by EFSD.
Review criteria are as follows:
- Significance: Does the study address an important problem in keeping with the goals and focus areas of this Programme? If the aims of the application are achieved, how will scientific knowledge be advanced? What will be the effect of the proposed studies on the concepts or methods that drive this field?
- Approach: Are the conceptual framework, design, methods and analyses adequately developed, well integrated, and appropriate to the aims of the project? Does the applicant acknowledge potential problem areas and consider alternative tactics?
- Innovation: Does the project employ novel concepts, approaches or methods? Are the aims original and innovative? Does the project challenge existing paradigms or develop new methodologies or technologies?
- Investigator: Is the investigator appropriately trained and well suited to carry out this work? Is the work proposed appropriate to the experience level of the principal investigator and other researchers, if any?
- Environment: Does the scientific environment in which the work will be done contribute to the probability of success? Do the proposed experiments take advantage of unique features of the scientific environment or employ useful collaborative arrangements? Is there evidence of institutional support?
- Budget: Is the requested budget appropriate for the proposed study?
Competitive
Renewal
Applications for a grant renewal grant will be accepted on a competitive basis,
with the same review process as described in this Announcement. Such
applications will thus be considered in the same fashion as all other new
applications received for review and without any special priority. Reporting Requirements
All investigators funded by this Programme are required to
submit a scientific progress report at the end of the project period.
For those projects where funding is distributed over a period of more than one
year, interim progress reports will also be required.
Such reports will be subject to assessment prior to the release of any
further funds.
Investigators must provide EFSD with copies of papers accepted
for publication, and must acknowledge the support of the Programme in all
written material by use of the phrase: "supported by an
EFSD/Novo Nordisk research grant".
Schedule
| Official Announcement: |
January 2010 |
| Application Deadline: |
01 April 2010 |
| Anticipated Award: |
July 2010 |
Enquiries should be directed to:
European Foundation for the Study of Diabetes
Rheindorfer Weg 3
40591 Düsseldorf, Germany
Tel: +49-211-75 84 69 0
Fax: + 49-211-75 84 69 29
E-mail: Foundation(a)easd.org
|